Summary
This 8-K filing from Alnylam Pharmaceuticals, Inc. reports on the separation agreement and consulting arrangement with its former Vice President, Finance and Treasurer, Patricia L. Allen. Ms. Allen resigned effective February 28, 2011, and her departure was formalized on March 21, 2011. The company has provided Ms. Allen with a severance package, including a cash payment equivalent to 12 months of her base salary, continued COBRA premium coverage for a year, and a consulting agreement for up to 12 months. This arrangement ensures a smooth transition for financial operations and leverages Ms. Allen's expertise during the interim period. For investors, this filing indicates a normal course of business transition within the finance department. The provided severance and consulting agreement appear to be standard for a departing executive and aim to minimize disruption to the company's financial reporting and treasury functions. The continued vesting of stock options during the consulting period suggests an alignment of incentives and a commitment to retaining valuable knowledge within the company as it navigates this change.
Key Highlights
- 1Patricia L. Allen, VP of Finance and Treasurer, resigned on February 28, 2011.
- 2A separation agreement was finalized on March 21, 2011.
- 3Alnylam will pay Ms. Allen severance of $250,397, equivalent to 12 months of her base salary.
- 4The company will cover Ms. Allen's COBRA premiums until March 31, 2012, or until she gains new employer coverage.
- 5Ms. Allen will provide consulting services to Alnylam for up to 12 months under a separate consulting agreement.
- 6Consulting services will focus on accounting, budgeting, financial reporting, and treasury activities.
- 7Unvested stock options held by Ms. Allen will continue to vest during the consulting period.